Latest Sobrera Pharma News & Updates

See the latest news and media coverage for Sobrera Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Sobrera Pharma

Biopharmaceutical company developing addiction treatments

sobrera.com
Headquarters
Gothenburg, Sweden
Company type
Private company
Number of employees
5–10

Last updated

Latest news about Sobrera Pharma

In short: Sobrera Pharma secured over 20 million SEK in funding and reported positive Phase 2 trial results for its Alcohol Use Disorder treatment.

Company announcements

  • Sobrera Pharma

    Sobrera Pharma completes oversubscribed financing round

    The round exceeds SEK 20 million target, attracting international investors. Funds support SO-001 development toward Phase 2b readiness.

  • Sobrera Pharma

    Sobrera Pharma appoints Gamgort and Hallmayer to board

    Appointments bring commercialization and industrial expertise ahead of 2026 milestones. Chairman and CEO highlight strengthened leadership for execution phase.

  • Sobrera Pharma

    Sobrera Pharma shares phase 2 study results

    Prof. Bo Söderpalm and Dr. Andrea de Bejczy discuss positive outcomes in Alcohol Use Disorder, published in The Lancet Regional Health Europe in July 2025.

  • Sobrera Pharma

    Sobrera Pharma shares varenicline-bupropion trial

    Randomized double-blind placebo-controlled multicentre trial assesses efficacy and safety alone and combined for alcohol use disorder.

Unlock all announcements with a

Media coverage

Be the first to know. to get notified the second Sobrera Pharma hits the news.

Never miss news about Sobrera Pharma

Track Sobrera Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.